Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Praveenkumar Murugavelu"'
Autor:
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh K Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Sanjeev Kumar, Kamini Jakhar, Sudipta Sonar, Anil Kumar Panchal, Manas Ranjan Tripathy, Shirlie Roy Chowdhury, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Kalpana Luthra, Gaurav Batra, Devinder Sehgal, Guruprasad R Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Kumar Garg, Deepak T Nair, Rajesh Kumar
Publikováno v:
PLoS Pathogens, Vol 18, Iss 12, p e1010994 (2022)
The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic monoclonal antibodies (mAbs). Here, we report an extremely potent mAb named P4A2 that can neutralize all the circulating variants of concern (V
Externí odkaz:
https://doaj.org/article/3ba087963a9548d5823331f44d97566f
Autor:
Vanshika Singh, Sweety Samal, Ritika Khatri, Kalpana Luthra, Tripti Shrivastava, Chandresh Sharma, Rajesh Kumar, Shubbir Ahmed, Praveenkumar Murugavelu, Reshma Perween, Subrata Sinha, Hilal Ahmad Parray, Shivangi Shukla
Publikováno v:
Applied Microbiology and Biotechnology
The route of administration of a therapeutic agent has a substantial impact on its success. Therapeutic antibodies are usually administered systemically, either directly by intravenous route, or indirectly by intramuscular or subcutaneous injection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3931f4909df1a84dc4699cdce5bed846
https://doi.org/10.1007/s00253-021-11488-4
https://doi.org/10.1007/s00253-021-11488-4
Autor:
Rajesh Kumar, Hilal Parray, Naveen Narayan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Kamini Jakhar, Sudipta Sonar, Shirlie Chowdhury, Anil Panchal, Manas Tripathy, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Gaurav Batra, Devinder Sehgal, Guruprasad Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Garg, Deepak Nair
The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic mAbs. Here, we report an extremely potent mAb named P4A2 that can neutralize all the circulating variants of concerns (VOCs) with high efficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90321952534c9479c085578e48e99bd6
https://doi.org/10.21203/rs.3.rs-1431974/v1
https://doi.org/10.21203/rs.3.rs-1431974/v1
Autor:
Perween, Reshma, PraveenKumar, Murugavelu, Shrivastava, Tripti, Parray, Hilal Ahmed, Singh, Vanshika, Singh, Swarandeep, Chiranjivi, Adarsh, Jakhar, Kamini, Sonar, Sudipta, Tiwari, Mahima, Reema, Panchal, Anil Kumar, Sharma, Chandresh, Rathore, Deepak Kumar, Ahamed, Shubbir, Samal, Sweety, Mani, Shailendra, Bhattacharyya, Sankar, Das, Supratik, Luthra, Kalpana, Kumar, Rajesh
Publikováno v:
In International Immunopharmacology December 2021 101 Part B
Autor:
Kamini Jakhar, Reshma Perween, Adarsh Kumar Chiranjivi, Rajesh Kumar, Hilal Ahmad Parray, Ritika Khatri, Naveen S Yadav, Sweety Samal, Shubbir Ahmed, Pallavi Kshetrapal, Shailendra Mani, Kalpana Luthra, Supratik Das, Sudipta Sonar, S. K. Singh, Ramachandran Thiruvengadam, Shinjini Bhatnagar, Tripti Shrivastava, Praveenkumar Murugavelu, Chandresh Sharma, Vanshika Singh, Sankar Bhattacharyya, Preeti Vishwakarma, Anil Kumar Panchal, Savita Singh
Publikováno v:
International Immunopharmacology
The spike protein of the SARS-CoV-2 virus is the foremost target for the designing of vaccines and therapeutic antibodies and also acts as a crucial antigen in the assessment of COVID-19 immune responses. The enveloped viruses; such as SARS-CoV-2, Hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e00f29e9bece996afb840d867740f33
http://europepmc.org/articles/PMC8318684
http://europepmc.org/articles/PMC8318684